News and features

Testing the activity of as few as six key genes is helping to identify women with particularly aggressive breast cancer.

Researchers have uncovered a key part of a chain reaction of signals that tell some lung cancers to grow. This new insight into a major cancer signalling pathway could prioritise new drug targets.

Researchers at The Institute of Cancer Research, London, are investigating new ways to use molecular imaging to predict how a person will respond to cancer treatment. Liz Burtally finds out how.

The Cancer Research Technology (CRT) Pioneer Fund has today (Thursday) announced its investment in research to develop new drugs called heat-shock factor 1 (HSF1) pathway inhibitors, which have the potential to block a protective mechanism used by cancer cells.

Tim Morgan has faced an extraordinary challenge this month in a cycle ride pitched as the 'hardest event in the Cycling Weekly Sportive Series' to raise funds for cancer research. His amazing efforts have already raised almost £250,000.

Pioneering cancer researcher Professor Richard Marais is taking on a 112-mile cycle challenge to raise funds in memory of Professor Chris Marshall – an outstanding and inspirational scientist whose work led to the development of new cancer treatments.

Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit from a new class of cancer drug designed to overcome drug resistance, a new study suggests.

Two world-leading scientists at The Institute of Cancer Research, London, have been made Fellows of the Royal Society – one of the greatest honours in UK science.

Professor Clare Isacke has been elected to the Academy of Medical Sciences in recognition of her outstanding contribution to the advancement of cancer research.

The Institute of Cancer Research, London, is committed to creating a supportive work environment, providing good career support for both women and men, and to remove any unnecessary barriers to career progression. Our efforts to address gender inequality have been recognised with a prestigious Athena SWAN Silver Award.

As in previous years, The Institute of Cancer Research, London, had an inspiring team of runners taking part in the prestigious London Marathon. This year, #teamICR comprised of 25 runners who are set to raise an outstanding amount of money that will help fund our research.

An early blood test could help doctors identify which patients will benefit from treatment for advanced prostate cancer, according to a new study.